Subscribe to Updates

    Get the latest health news from HerCancer about cancer & its various facts and treatments .

    What's Hot

    Oklahoma scientists develop promising cancer drug

    June 16, 2022

    Camp Kemo provides community for kids dealing with cancer

    June 16, 2022

    OU OK-1 cancer treatment drug heads to clinical trial

    June 15, 2022
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Her CancerHer Cancer
    Subscribe
    • Home
    • Women’s Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
    • Gynecologic Cancers
    Her CancerHer Cancer
    Home»Cervical Cancer»Reprogrammed Cells Attack and Tame Deadly Cancer in One Woman
    Cervical Cancer

    Reprogrammed Cells Attack and Tame Deadly Cancer in One Woman

    adminBy adminJune 1, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Dr. Elizabeth Jaffee, a pancreatic cancer specialist at Johns Hopkins Medicine also highlighted the location of the patient’s metastases, or where the cancer had spread to. Metastases arose only in the patient’s lungs. Most pancreatic cancer patients have metastases in their liver that are more difficult to treat.

    “I would like to see liver lesions go away,” Dr. Jaffee said.

    Kathy Wilkes, the patient who was successfully treated, is 71 and lives in Ormond-by-the-Sea, Fla. It is too soon to know if the cancer will come roaring back.

    New Developments in Cancer Research


    Card 1 of 6

    Progress in the field. In recent years, advancements in research have changed the way cancer is treated. Here are some recent updates:

    Chemotherapy. A quiet revolution is underway in the field of cancer treatment: A growing number of patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.

    Leukemia. After receiving a new treatment, called CAR T cell therapy, more than a decade ago, two patients with chronic lymphocytic leukemia saw the blood cancer vanish. Their cases offer hope for those with the disease, and create some new mysteries.

    Esophageal cancer. Nivolumab, a drug that unleashes the immune system, was found to extend survival times in patients with the disease who took part in a large clinical trial. Esophageal cancer is the seventh most common cancer in the world.

    Ms. Wilkes’ cancer was severe.

    “This lady had had all of the available treatments and was failing,” said Dr. Jarnagin, who did not treat Ms. Wilkes but reviewed her case. Usually, in such cases, the cancer has developed resistance to any additional treatments.

    “For most in that situation the cancer is going to win — soon,” he said.

    Ms. Wilkes first noticed symptoms that were later attributed to pancreatic cancer in 2015. She was tired, lethargic and had bouts of intense pain. At first, tumors did not appear on scans. But by early 2018, a tumor showed up — a 3.5-centimeter mass in the head of her pancreas.

    She had chemotherapy followed by a grueling operation — the Whipple procedure — in which surgeons remove the head of the pancreas, the first part of the small intestine, the gallbladder and the bile duct. Then she had more chemotherapy, followed by radiation and even more chemotherapy.

    The cancer was gone from her pancreas, but nodules appeared in her lungs — metastases. The chemotherapy and radiation continued throughout 2018.

    “I just went through with it. I certainly wasn’t ready to die,” Ms. Wilkes said. “I had this voice inside saying, ‘You can best this one.’”

    admin
    • Website

    Related Posts

    Camp Kemo provides community for kids dealing with cancer

    June 16, 2022

    Biden May Stop His Cancer Moonshot’s Launch

    June 15, 2022

    Ohio teen with spinal cancer earns title of honorary Marine: ‘Amazing young man’

    June 15, 2022

    Leave A Reply Cancel Reply

    Don't Miss
    Ovarian Cancer

    Oklahoma scientists develop promising cancer drug

    By adminJune 16, 20220

    Dena Newlun, a patient at OU Health Stephenson Cancer Center, talks about the importance of…

    Camp Kemo provides community for kids dealing with cancer

    June 16, 2022

    OU OK-1 cancer treatment drug heads to clinical trial

    June 15, 2022

    Megyn Kelly Torches Fox News Over Segment Celebrating Child Mutilation

    June 15, 2022
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    Our Picks

    Oklahoma scientists develop promising cancer drug

    June 16, 2022

    Camp Kemo provides community for kids dealing with cancer

    June 16, 2022

    OU OK-1 cancer treatment drug heads to clinical trial

    June 15, 2022

    Megyn Kelly Torches Fox News Over Segment Celebrating Child Mutilation

    June 15, 2022

    Subscribe to Updates

    Get the latest health news from HerCancer about cancer & its various facts and treatments .

    Facebook Twitter Instagram
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms
    © 2022 . Designed by HerCancer.

    Type above and press Enter to search. Press Esc to cancel.